Literature DB >> 32269471

Stimulant Medication Prescribing Practices Within a VA Health Care System.

Caroline Richmond1, Justin Butler1.   

Abstract

Setting clear expectations for patients and prescribers before and during prescription use and the development of a clinical practice protocol may improve patient misuse of stimulant medications.
Copyright © 2020 Frontline Medical Communications Inc., Parsippany, NJ, USA.

Entities:  

Year:  2020        PMID： 32269471      PMCID： PMC7138341     

Source DB:  PubMed          Journal:  Fed Pract        ISSN： 1078-4497


  5 in total

1.  Prevalence and Correlates of Prescription Stimulant Use, Misuse, Use Disorders, and Motivations for Misuse Among Adults in the United States.

Authors:  Wilson M Compton; Beth Han; Carlos Blanco; Kimberly Johnson; Christopher M Jones
Journal:  Am J Psychiatry       Date:  2018-04-16       Impact factor: 18.112

Review 2.  Recent Trends in Stimulant Usage.

Authors:  Daniel J Safer
Journal:  J Atten Disord       Date:  2015-10-20       Impact factor: 3.256

3.  Risk of amphetamine use disorder and mortality among incident users of prescribed stimulant medications in the Veterans Administration.

Authors:  Arthur N Westover; Paul A Nakonezny; Ethan A Halm; Bryon Adinoff
Journal:  Addiction       Date:  2018-01-09       Impact factor: 6.526

4.  Trends in office-based treatment of adults with stimulants in the United States.

Authors:  Mark Olfson; Carlos Blanco; Shuai Wang; Laurence L Greenhill
Journal:  J Clin Psychiatry       Date:  2013-01       Impact factor: 4.384

5.  Continuity in methylphenidate treatment of adults with attention-deficit/hyperactivity disorder.

Authors:  Mark Olfson; Steven C Marcus; Huabin F Zhang; George J Wan
Journal:  J Manag Care Pharm       Date:  2007-09
  5 in total
  1 in total

1.  Analysis of Stimulant Prescriptions and Drug-Related Poisoning Risk Among Persons Receiving Buprenorphine Treatment for Opioid Use Disorder.

Authors:  Carrie M Mintz; Kevin Y Xu; Ned J Presnall; Sarah M Hartz; Frances R Levin; Jeffrey F Scherrer; Laura J Bierut; Richard A Grucza
Journal:  JAMA Netw Open       Date:  2022-05-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.